Fampridine
Key facts
| Active substance |
Fampridine
|
| Therapeutic area |
Neurology
|
| Decision number |
P/213/2010
|
| PIP number |
Fampridine
|
| Pharmaceutical form(s) |
Prolonged-release tablet
|
| Condition(s) / indication(s) |
Multiple sclerosis with walking disability
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Acorda Therapeutics, Inc.
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|